Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia (2018)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2018.00901
- Subjects: CANABINOIDES; ESQUIZOFRENIA; SEROTONINA; MODELOS ANIMAIS DE DOENÇAS
- Keywords: Schizophrenia; Cannabidiol; SHR strain; Prevention; Side effects; Animal models; Serotonin; BDNF
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 9, art. 901, 2018
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
PERES, Fernanda Fiel et al. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00901. Acesso em: 09 maio 2026. -
APA
Peres, F. F., Diana, M. C., Levin, R., Suiama, M. A., Almeida, V., Vendramini, A. M., et al. (2018). Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00901 -
NLM
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2026 maio 09 ] Available from: https://doi.org/10.3389/fphar.2018.00901 -
Vancouver
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2026 maio 09 ] Available from: https://doi.org/10.3389/fphar.2018.00901 - Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol reverses memory impairments and activates components of the Akt/GSK3β pathway in an experimental model of estrogen depletion
- Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
